Open Access Article
Matvei Yu.
Martynov
a,
Roman O.
Iakovenko
a,
Anna N.
Kazakova
a,
Irina A.
Boyarskaya
a and
Aleksander V.
Vasilyev
*ab
aInstitute of Chemistry, Saint Petersburg State University, Universitetskaya nab., 7/9, Saint Petersburg, 199034, Russia
bDepartment of Chemistry, Saint Petersburg State Forest Technical University, Institutsky per., 5, Saint Petersburg, 194021, Russia. E-mail: aleksvasil@mail.ru
First published on 27th February 2017
2,4-Diaryl-1,1,1-trifluorobut-3-en-2-oles and their TMS-ethers in H2SO4 at room temperature in just 2 min are quantitatively cyclized into 1-aryl-3-trifluoromethyl-1H-indenes. The reaction proceeds through an intermediate formation of the corresponding CF3-allyl cations, which are cyclized regioselectively at the allyl carbon atom most remote from the CF3-group. The obtained CF3-indenes in solution of EtOAc in the presence of silica gel at room temperature over 4 h are quantitatively isomerized into 3-aryl-1-trifluoromethyl-1H-indenes.
The main goal of this work was a study of acid-promoted electrophilic transformation of 2,4-diaryl-1,1,1-trifluorobut-3-en-2-oles 2 and their TMS-ethers 1. CF3-TMS-ethers 1 are easily available from chalcones by trifluoromethylation of the carbonyl group with CF3TMS followed by desilylation with SnCl2 or aqueous HCl leading to CF3-allyl alcohols 2 (Scheme 1).
![]() | ||
| Scheme 1 Synthesis of CF3-TMS-ethers 1 and the corresponding CF3-alcohols 2 from chalcones (see substituents R1, R2 in aryl rings Ar1, Ar2, respectively, in Table 1). | ||
Then we carried out reactions of the series of compounds 1/2 under the action of various acidic reagents (Table 1). Indeed, the cyclization of 1/2 into CF3-indenes 3 takes place showing that carbon C4 is a reactive center in the corresponding intermediate cations A. Among all other tested Brønsted and Lewis acids, sulfuric acid (H2SO4) was found to be one of the best for this transformation, and the reaction in this acid took just 2 min (Table 1). Alcohol 2a was not converted into acetic acid (room temperature, 4 h), and remained unreacted. On the other hand, strong Lewis acids AlX3 (X = Cl, Br) in the reaction with 2a led to complex oligomeric mixtures. The same reaction in trifluoroacetic needed a longer time (room temperature, 1 h) and gave 3a in 88% yield. Triflic acid CF3SO3H (TfOH) may be used as well; indene 3a was formed in 2–3 min in 82% yield in this acid. However, we finally chose H2SO4 because it is a cheap and easy to handle reagent.
| Entry | Starting compounds | Reaction products | |||
|---|---|---|---|---|---|
| 1/2 | R1, R2 in 1/2, R2 in 3 | R1 |
3 a (yield, %) |
||
| R1 | R2 | ||||
a Isolated yields.
b Yield obtained with the reaction in CF3CO2H (50 equiv.), instead of H2SO4, for 5 min.
c Two regioisomers 3j1 and 3j2 with a ratio 1.25 : 1 and 96% yield were obtained.
d The mixture of isomeric indenes 3q and 4q in a ratio of 8 : 1, respectively, was obtained (see Scheme 2).
|
|||||
| 1 | 1a/2a | H | H | H | 3a (90) |
| 2 | 1b/2b | 4-Me | H | 6-Me | 3b (99) |
| 3 | 1c/2c | H | 4-Me | H | 3c (99) |
| 4 | 1d/2d | 4-Me | 4-Me | 6-Me | 3d (99) |
| 5 | 1e/2e | 4-MeO | H | 6-MeO | 3e (97) (97b) |
| 6 | 1f/2f | H | 4-MeO | H | 3f (97) (97b) |
| 7 | 1g/2g | 3,4-Di(MeO) | H | 5,6-Di(MeO) | 3g (95) (98b) |
| 8 | 1h/2h | 4-MeO | 4-MeO | 6-MeO | 3h (10) (92b) |
| 9 | 1i/2i | 4-Me | 3,4-Di(MeO) | 6-Me | 3i (20) (50b) |
| 10c | 1j/2j | 3,4-Di(Me) | H | 5,6-Di(Me) | 3j1 (53) |
| 6,7-Di(Me) | 3j2 (43) | ||||
| 11 | 1k | 2,4-Di(Me) | H | 4,6-Di(Me) | 3k (97) |
| 12 | 1l | 2,5-Di(Me) | H | 4,7-Di(Me) | 3l (97) |
| 13 | 1m/2m | 2,4,6-Tri(Me) | H | 4,6,7-Tri(Me) | 3m (97) |
| 14 | 1n/2n | H | 3,4-OCH2O | H | 3n (68) (91b) |
| 15 | 1o/2o | H | 4-Cl | H | 3o (97) |
| 16 | 1p | 4-F | 3,4-Di(Me) | 6-F | 3p (97) |
| 17 | 1q | 4-F | 3,4-Di(MeO) | 6-F | 3q (74)d |
Both CF3-TMS-ethers 1 and CF3-allyl alcohols 2 gave the same indenes with the same high yields (Table 1). In most of the cases, the formation of indenes 3a–q was quantitative (Table 1). However, in H2SO4 compounds 3h and 3i bearing donating methoxy groups were formed in low yields of 10 and 20%, respectively, due to the consequent transformations of these electron-rich indenes in H2SO4. The use of less acidic CF3CO2H resulted in much higher yields of 3h and 3i, 92 and 50%, respectively (entries 8 and 9).
It should be noted that starting compounds 1/2, bearing both electron withdrawing and donating substituents R1, R2 in aryl rings Ar1, Ar2, respectively, led to the exclusive formation of indenes 3, formed by the cyclization at carbon C4 in CF3-allyl cations A (see Fig. 1). The formation of alternative indene structures by cyclization at carbon C2 in species A was not observed at all. This regioselectivity in reactions of CF3-cations A is contrary to the non-selective behaviour of other allyl cations without the CF3-substituent.20
Despite that indenes 3 were formed quantitatively without any further purification, under the attempt of their additional column chromatography isolation with silica gel, the isomerization into other indenes 4 was observed (Scheme 2). Thus, we developed the procedure for this quantitative isomerization by stirring a solution of compounds 3 in EtOAc in the presence of silica gel at room temperature for 4 h (see Scheme 2 for selected indenes 3/4). Compared with compounds 3, their isomers 4 should be thermodynamically more stable, because of the additional conjugation of the indene C2
C3 double bond with the aryl group Ar2. Some of the indenes 3 were isomerized very easily. Thus, under the isolation (without column chromatography with silica gel) of 3q, the additional formation of the corresponding isomeric indene 4q was observed (entry 17, Table 1). On the other hand, polymethylated indenes 3j2, 3l and 3m, bearing a methyl group in the position 7 of the indene system, were not isomerized at all, presumably, because of the steric hindrance from this methyl substituent. Most likely, the presence of the substituent in the indene position 7 is a crucial point for this isomerization. Any bulky group in this position may disturb a flat orientation of ring Ar2 relatively to the indene plane, which is thermodynamically favorable for conjugation of their π-systems. A shift of the double bond in the indene system with a formation of isomeric indenes has also been observed under the action of various basic or acidic reagents.13,21–23
![]() | ||
| Scheme 2 Isomerization of CF3-indenes 3 into 4 (see substituents R1, R2 in aryl rings Ar1, Ar2, respectively, in Table 1). | ||
CH, J 16.3 Hz), 6.71 d (1H,
CH, J 16.3 Hz), 7.29–7.43 m (8Harom.), 7.60–7.62 m (2Harom.). 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.40 s (CF3). HRMS: C19H21F3OSiAg found 457.0360 [M + Ag]+; calcd 457.0359.
CH, J 16.3 Hz), 6.72 d (1H,
CH, J 16.3 Hz), 7.21 d (2Harom., J 8.1 Hz), 7.29–7.43 m (5Harom.), 7.49 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 21.2 (Me), 80.0 q (C2, JC–F 28.8 Hz), 125.2 q (CF3, JC–F 286.8 Hz), 127.0, 127.2, 128.0, 128.7, 128.8, 128.9, 135.2, 135.2, 135.9, 138.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.57 s (CF3). HRMS: C20H23F3OSiAg found 471.0517 [M + Ag]+; calcd 471.0516.
CH, J 16.4 Hz), 6.66 d (1H,
CH, J 16.4 Hz), 7.17 d (2Harom., J 8.0 Hz), 7.31 d (2Harom., J 8.0 Hz), 7.36–7.43 m (3Harom.), 7.60–7.62 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 21.4 (Me), 80.1 q (C2, JC–F 28.8 Hz), 125.2 q (CF3, JC–F 286.6 Hz), 126.0, 126.9, 128.0, 128.1, 128.6, 129.7, 133.1, 135.4, 138.2, 138.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.57 s (CF3). HRMS: C20H23F3OSiAg found 471.0507 [M + Ag]+; calcd 471.0516.
CH, J 16.3 Hz), 6.67 d (1H,
CH, J 16.3 Hz), 7.17 d (2Harom., J 8.0 Hz), 7.20 d (2Harom., J 8.1 Hz), 7.31 d (2Harom., J 8.0 Hz), 7.49 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 21.2 (Me), 21.4 (Me), 80.0 q (C2, JC–F 28.7 Hz), 125.2 q (CF3, JC–F 286.6 Hz), 126.1, 126.9, 128.1, 128.8, 129.6, 133.2, 135.2, 135.3, 138.4, 138.7. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.75 c (CF3). HRMS: C21H25F3OSiAg found 485.0668 [M + Ag]+; calcd 485.0672.
CH, J 16.3 Hz), 6.64 d (1H,
CH, J 16.3 Hz), 6.91 d (2Harom., J 8.7 Hz), 7.37 d (2Harom., J 8.7 Hz), 7.40–7.42 m (3Harom.), 7.63–7.65 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 55.4 (OMe), 80.2 q (C2, J 28.8 Hz), 114.4, 124.7, 125.2 q (CF3, J 286.5 Hz), 128.0, 128.2, 128.3, 128.6, 128.6, 135.1, 138.3, 160.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.64 c (CF3). HRMS: C20H23F3O2SiAg found 487.0469 [M + Ag]+; calcd 487.0465.
CH, J 16.3 Hz), 6.73 d (1H,
CH, J 16.3 Hz), 6.93 d (2Harom., J 8.6 Hz), 7.30–7.37 m (3Harom.), 7.42–7.44 m (2Harom.), 7.53 d (2Harom., J 8.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 55.4 (OMe), 79.8 q (C2, JC–F 28.9 Hz), 113.4, 125.2 q (CF3, JC–F 286.5 Hz), 127.0, 127.2, 128.7, 128.9, 129.5, 130.0, 135.2, 135.9, 159.9. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.73 c (CF3). HRMS: C20H23F3O2SiAg found 487.0477 [M + Ag]+; calcd 487.0465.
CH, J 16.3 Hz), 6.71 d (1H,
CH, J 16.3 Hz), 6.88 d (1Harom., J 9.0 Hz), 7.14–7.15 m (2Harom.), 7.26–7.43 m (5Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 s (SiMe3), 56.0 (OMe), 56.0 (OMe), 79.9 q (C2, JC–F 28.7 Hz), 110.5, 111.6, 120.8, 125.2 q (CF3, JC–F 287.0 Hz), 127.0, 127.0, 128.8, 129.0, 130.4, 135.4, 135.9, 148.5, 149.3. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.64 c (CF3). HRMS: C21H25F3O2SiAg found 517.0559 [M + Ag]+; calcd 517.0571.
CH, J 16.3 Hz), 6.62 d (1H,
CH, J 16.3 Hz), 6.89 d (2Harom., J 8.7 Hz), 6.92 d (2Harom., J 8.8 Hz), 7.35 d (2Harom., J 8.7 Hz), 7.52 d (2Harom., J 8.8 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 55.4 (OMe), 55.5 (OMe), 79.9 q (C2, JC–F 29.0 Hz), 113.4, 114.4, 124.9, 125.3 q (CF3, JC–F 286.6 Hz), 128.3, 128.6, 129.5, 130.2, 134.9, 159.8, 160.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.02 c (CF3). HRMS: C21H25F3O2SiAg found 517.0550 [M + Ag]+; calcd 517.0571.
CH, J 16.3 Hz), 6.61 d (1H,
CH, J 16.3 Hz), 6.85 d (1Harom., J 8.3 Hz), 6.93 d (1Harom., J 1.9 Hz), 6.96 dd (1Harom., J 8.3 Hz, J 1.9 Hz), 7.21 d (2Harom., J 8.1 Hz), 7.49 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 21.2 (Me), 56.1 (OMe), 56.1 (OMe), 80.1 q (C2, J 28.8 Hz), 104.4, 109.4, 111.4, 120.3, 125.1, 125.2 q (CF3, JC–F 286.5 Hz), 128.1, 128.8, 128.9, 135.1, 135.2, 138.4, 149.4, 149.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.68 (CF3). HRMS: C22H27F3O3SiAg found 531.0727 [M + Ag]+; calcd 531.0731.
CH, J 16.3 Hz), 6.73 d (1H,
CH, J 16.3 Hz), 7.16 d (1Harom., J 7.8 Hz), 7.29–7.39 m (5Harom.), 7.42–7.44 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 19.6 (Me), 20.2 (Me), 80.0 q (C2, JC–F 28.8 Hz), 125.2 q (CF3, JC–F 286.7 Hz), 125.5, 127.0, 127.3, 128.7, 128.9, 129.2, 129.4, 135.0, 135.5, 136.0, 136.2, 137.1. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.41 c (CF3). HRMS: C21H25F3OSiAg found 485.0668 [M + Ag]+; calcd 485.0672.
CH, J 16.4 Hz), 6.67 d (1H,
CH, J 16.4 Hz), 7.01–7.03 m (2Harom.), 7.27–7.42 m (5Harom.), 7.50 d (1Harom., J 7.7 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 1.8 (SiMe3), 21.0 (Me), 22.6 (Me), 81.0 q (C2, JC–F 28.5 Hz), 125.6 q (CF3, JC–F 287.4 Hz), 126.2, 126.9, 128.3, 128.5, 128.9, 133.7, 133.8, 134.1, 136.2, 138.0, 138.3. 19F NMR (CDCl3, 376 MHz) δ, ppm: −74.50 c (CF3). HRMS: C21H25F3OSiAg found 485.0664 [M + Ag]+; calcd 485.0672.
CH, J 16.4 Hz), 6.68 d (1H,
CH, J 16.4 Hz), 7.08 m (2Harom.), 7.28–7.37 m (3Harom.), 7.40–7.42 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 1.7 (SiMe3), 21.3 (Me), 22.2 (Me), 81.0 q (C2, JC–F 28.6 Hz), 125.5 q (CF3, JC–F 287.6 Hz), 126.8, 128.1, 128.4, 128.8, 129.0, 129.2, 132.8, 134.1, 134.7, 134.9, 136.1, 136.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −74.24 c (CF3). HRMS: C21H25F3OSiAg found 485.0662 [M + Ag]+; calcd 485.0672.
CH, J 16.4 Hz), 6.69 d (1H,
CH, J 16.4 Hz), 6.97 s (1Harom.), 7.27–7.43 m (6Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 1.7 (SiMe3), 19.2 (Me), 19.5 (Me), 22.0 (Me), 80.8 q (C2, JC–F 28.5 Hz), 125.4 q (CF3, JC–F 287.6 Hz), 126.7, 128.2, 128.3, 128.7, 129.6, 133.2, 133.6, 133.9, 134.2, 135.1, 136.1, 136.7. 19F NMR (CDCl3, 376 MHz) δ, ppm: −74.54 c (CF3). HRMS: C22H27F3OSiAg found 499.0834 [M + Ag]+; calcd 499.0829.
CH, J 16.2 Hz), 6.59 d (1H,
CH, J 16.2 Hz), 6.78 d (1Harom., J 8.0 Hz), 6.83 d (1Harom., J 8.0 Hz), 6.96 s (1Harom.), 7.36–7.42 m (3Harom.), 7.59–7.61 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.2 (SiMe3), 80.1 q (C2, JC–F 28.8 Hz), 101.4, 105.9, 108.6, 122.2, 125.2 q (CF3, JC–F 286.3 Hz), 125.2, 128.0, 128.1, 128.6, 130.3, 135.2, 138.2, 148.3, 148.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.59 c (CF3). HRMS: C20H21F3O3SiAg found 501.0252 [M + Ag]+; calcd 501.0258.
CH, J 16.3 Hz), 6.67 d (1H,
CH, J 16.3 Hz), 7.34 s (4Harom.), 7.38–7.43 m (3Harom.), 7.59–7.61 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.1 (SiMe3), 80.1 q (C2, JC–F 29.0 Hz), 125.1 q (CF3, JC–F 286.8 Hz), 127.9, 128.0, 128.2, 128.2, 128.8, 129.2, 133.9, 134.4, 134.6, 138.0. 19F NMR (CDCl3, 376 MHz) δ, ppm: −77.19 c (CF3). HRMS: C21H25F335ClOSiAg found 490.9965 [M + Ag]+; calcd 490.9969.
CH, J 16.4 Hz), 6.61 d (1H,
CH, J 16.4 Hz), 7.05–7.18 m (5Harom.), 7.59 dd (2Harom., J 8.6 Hz, J 5.5 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.1 (SiMe3), 19.6 (Me), 19.8 (Me), 79.8 q (C2, JC–F 29.0 Hz), 114.8 d (JC–F 21.5 Hz), 124.3, 125.1 q (CF3, JC–F 286.6 Hz), 125.3, 128.3, 130.1 d (J 8.2 Hz), 130.2, 133.2, 134.1 d (JC–F 3.1 Hz), 135.9, 137.2, 137.7, 162.9 d (JC–F 247.6 Hz). 19F NMR (CDCl3, 376 MHz) δ, ppm: −113.96 c (1Farom.), −77.95 c (CF3). HRMS: C21H24F4OSiAg found 503.0570 [M + Ag]+; calcd 503.0578.
CH, J 16.3 Hz), 6.57 d (1H,
CH, J 16.3 Hz), 6.85 d (1Harom., J 8.3 Hz), 6.92 d (1Harom., J 1.9 Hz), 6.96 dd (1Harom., J 8.3 Hz, J 1.9 Hz), 7.05–7.11 m (2Harom.), 7.58 dd (2Harom., J 8.6 Hz, J 5.4 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 2.1 s (SiMe3), 56.1 (OMe), 56.1 (OMe), 79.8 q (C2, JC–F 29.0 Hz), 109.3, 111.4, 114.9 d (JC–F 21.5 Hz), 120.4, 124.6, 125.1 q (CF3, JC–F 286.3 Hz), 128.6, 130.1 d (JC–F 8.3 Hz), 134.0 d (JC–F 3.2 Hz), 135.6, 149.4, 150.0, 163.0 d (JC–F 247.7 Hz). 19F NMR (CDCl3, 376 MHz) δ, ppm: −113.88 c (1Farom.), −77.90 c (CF3). HRMS: C21H24F4O3SiAg found 535.0484 [M + Ag]+; calcd 535.0476.
CH, J 16.1 Hz), 6.89 d (1H,
CH, J 16.1 Hz), 7.28–7.45 m (8Harom.), 7.65–7.67 m (2Harom.). 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.50 c (CF3). HRMS: C16H13F3OAg found 384.9957 [M + Ag]+; calcd 384.9964.
CH, J 16.1 Hz), 6.89 d (1H,
CH, J 16.1 Hz), 7.23 d (2Harom., J 8.1 Hz), 7.28–7.38 m (3Harom.), 7.43–7.45 m (2Harom.), 7.54 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.21 (Me), 77.4 q (C2, JC–F 29.0 Hz), 125.2 q (CF3, JC–F 286.0 Hz), 126.7, 126.9, 126.9, 127.1, 128.7, 128.9, 129.2, 133.5, 134.6, 135.7, 138.9. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.57 c (CF3). HRMS: C17H15F3OAg found 399.0124 [M + Ag]+; calcd 399.0120.
CH, J 16.1 Hz), 6.85 d (1H,
CH, J 16.1 Hz), 7.16 d (2Harom., J 8.0 Hz), 7.33 d (2Harom., J 8.0 Hz), 7.37–7.44 m (3Harom.), 7.65–7.67 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.4 (Me), 77.5 q (C2, JC–F 29.0 Hz), 125.2 q (CF3, JC–F 286.0 Hz), 125.6, 127.0, 127.0, 128.5, 128.9, 129.6, 132.9, 133.6, 137.6, 138.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.55 c (CF3). HRMS: C17H15F3OAg found 399.0110 [M + Ag]+; calcd 399.0120.
CH, J 16.1 Hz), 6.84 d (1H,
CH, J 16.1 Hz), 7.16 d (2Harom., J 8.0 Hz), 7.22 d (2Harom., J 8.1 Hz), 7.32 d (2Harom., J 8.0 Hz), 7.53 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2 (Me), 21.4 (Me), 77.4 q (C2, JC–F 28.6 Hz), 125.3 q (CF3, J 286.2 Hz), 125.7, 126.9, 127.0, 129.2, 129.6, 132.9, 133.5, 134.7, 138.7, 138.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.65 c (CF3). HRMS: C18H17F3OAg found 413.0267 [M + Ag]+; calcd 413.0277.
CH, J 16.1 Hz), 6.81 d (1H,
CH, J 16.1 Hz), 6.88 d (2Harom., J 8.8 Hz), 7.35–7.44 m (5Harom.), 7.64–7.66 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.5 (OMe), 77.5 q (C2, JC–F 28.6 Hz), 114.3, 124.4, 125.3 q (CF3, J 285.9 Hz), 127.0, 128.4, 128.4, 128.5, 128.9, 133.3, 137.7, 160.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.57 c (CF3). HRMS: C17H15F3O2Ag found 415.0089 [M + Ag]+; calcd 415.0070.
CH, J 16.1 Hz), 6.80 d (1H,
CH, J 16.1 Hz), 6.87 d (2Harom., J 8.8 Hz), 7.35–7.43 m (5Harom.), 7.64–7.65 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.5 (OMe), 77.5 q (C2, JC–F 28.9 Hz), 114.3, 124.4, 125.3 q (CF3, JC–F 286.1 Hz), 127.0, 128.3, 128.4, 128.4, 128.8, 133.3, 137.8, 160.1. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.59 c (CF3). HRMS: C17H15F3O2Ag found 415.0073 [M + Ag]+; calcd 415.0070.
CH, J 16.1 Hz), 6.88 d (1H,
CH, J 16.1 Hz), 6.88 d (1Harom., J 8.5 Hz), 7.16 d (1Harom., J 8.5 Hz), 7.19 s (1Harom.), 7.28–7.37 m (3Harom.), 7.43 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 56.0 (OMe), 56.1 (OMe), 77.5 q (C2, J 28.6 Hz), 110.3, 110.8, 119.8, 125.3 q (CF3, JC–F 286.1 Hz), 126.7, 127.0, 128.8, 128.9, 129.9, 133.7, 135.7, 148.9, 149.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.54 c (CF3). HRMS: C18H17F3O3Ag found 445.0178 [M + Ag]+; calcd 445.0175.
CH, J 16.1 Hz), 6.79 d (1H,
CH, J 16.1 Hz), 6.87 d (2Harom., J 8.7 Hz), 6.92 d (2Harom., J 8.8 Hz), 7.36 d (2Harom., J 8.7 Hz), 7.56 d (2Harom., J 8.8 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.4 (OMe), 55.5 (OMe), 77.2 q (C2, JC–F 28.6 Hz), 113.8, 114.3, 124.5, 125.3 q (CF3, JC–F 286.0 Hz), 128.3, 128.5, 129.8, 133.1, 159.9, 160.1. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.77 c (CF3). HRMS: C18H17F3O3Ag found 445.0173 [M + Ag]+; calcd 445.0175.
CH, J 16.0 Hz), 6.79 d (1H,
CH, J 16.0 Hz), 6.83 d (1Harom., J 8.1 Hz), 6.95–6.97 m (2Harom.), 7.22 d (2Harom., J 8.1 Hz), 7.53 d (2Harom., J 8.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2 (Me), 56.1 (OMe), 56.1 (OMe), 77.4 q (C2, J 28.8 Hz), 109.4, 111.3, 120.5, 124.7, 125.3 q (CF3, JC–F 285.8 Hz), 126.9, 128.8, 129.2, 133.5, 134.8, 138.8, 149.3, 149.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.49 c (CF3). HRMS: C19H19F3O3Ag found 459.0328 [M + Ag]+; calcd 459.0332.
CH, J 16.1 Hz), 6.89 d (1H,
CH, J 16.1 Hz), 7.17 d (1Harom., J 8.0 Hz), 7.27–7.36 m (4Harom.), 7.40 s (1Harom.), 7.42–7.44 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.5 (Me), 20.1 (Me), 77.3 q (C2, JC–F 28.8 Hz), 124.3, 125.3 q (CF3, JC–F 286.0 Hz), 126.9, 127.0, 127.9, 128.6, 128.8, 129.7, 133.2, 135.1, 135.9, 136.8, 137.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.50 c (CF3). HRMS: C18H17F3OAg found 413.0269 [M + Ag]+; calcd 413.0277.
CH, J 16.2 Hz), 6.75 d (1H,
CH, J 16.2 Hz), 6.99 s (1Harom.), 7.27–7.37 m (3Harom.), 7.42–7.43 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.3 (Me), 19.6 (Me), 22.0 q (Me, J 1.2 Hz), 78.9 q (C2, JC–F 28.6 Hz), 125.7 q (CF3, JC–F 286.7 Hz), 126.9, 127.5, 128.6, 128.9, 129.2, 132.8, 133.7, 134.0, 134.5, 135.1, 135.9, 137.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −76.72 c (CF3). HRMS: C19H19F3OAg found 427.0422 [M + Ag]+; calcd 427.0433.
CH, J 16.0 Hz), 6.77 d (1Harom., J 8.1 Hz), 6.77 d (1H,
CH, J 16.0 Hz), 6.85 dd (1Harom., J 8.1 Hz, J 1.5 Hz), 6.97 d (1Harom., J 1.5 Hz), 7.36–7.43 m (3Harom.), 7.63–7.64 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 77.4 q (C2, J 29.2 Hz), 101.4, 106.1, 108.5, 122.2, 124.8, 125.2 q (CF3, JC–F 285.8 Hz), 127.0, 128.5, 128.9, 130.1, 133.4, 137.6, 148.2, 148.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.57 c (CF3). HRMS: C17H13F3O3Ag found 428.9867 [M + Ag]+; calcd 428.9863.
CH, J 16.0 Hz), 6.85 d (1H,
CH, J 16.0 Hz), 7.30–7.45 m (7Harom.), 7.63–7.65 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 77.5 q (C2, JC–F 29.1 Hz), 125.1 q (CF3, JC–F 286.0 Hz), 126.8, 127.2, 128.3, 128.6, 129.0, 132.5, 134.2, 134.5, 137.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −78.40 c (CF3). HRMS: C16H12F335ClOAg found 418.9557 [M + Ag]+; calcd 418.9574.
CH), 7.12 d (2Harom., J 7.6 Hz), 7.28–7.33 m (5Harom.), 7.38 t (1Harom., J 7.4 Hz), 7.57 d (1Harom., J 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.6 (C1), 121.2, 122.5 q (CF3, J 270.0 Hz), 123.9, 126.6, 127.0, 127.6, 128.03, 129.1, 134.6 q (C3, J 34.3 Hz), 137.1, 138.2, 141.0 q (C2, J 5.0 Hz), 148.0. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.05 s (CF3). HRMS (MALDI): C16H12F3 found 261.0886 [M + H]+, calcd 261.0891.
CH), 7.12 d (2Harom., J 8.0 Hz), 7.13 c (1Harom.), 7.19 d (1Harom., J 7.8 Hz), 7.28–7.34 m (3Harom.), 7.44 d (1Harom., J 7.8 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.6 (Me), 55.4 (C1), 120.6, 122.6 q (CF3, J 270.0 Hz), 125.3, 127.5, 128.1, 128.3, 129.1, 134.5 q (C3, J 34.2 Hz), 135.5 d (C3a, J 1.1 Hz), 137.0, 137.4 d (C7a, J 0.8 Hz), 140.0 q (C2, J 5.1 Hz), 148.4. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.07 s (CF3). HRMS (MALDI): C17H14F3 found 275.1042 [M + H]+, calcd 275.1048.
CH), 7.12 d (2Harom., J 8.1 Hz), 7.26–7.32 m (2Harom.), 7.37 t.d (1Harom., J 7.6 Hz, J 1.5 Hz), 7.56 d (1Harom., J 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2 (Me), 55.3 (C1), 120.9, 122.6 q (CF3, J 270.0 Hz), 124.5, 126.9, 127.4, 127.9, 129.8, 133.9, 134.4 q (C3, J 34.2 Hz), 137.3, 138.2, 141.3 q (C2, J 5.0 Hz), 148.2. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.02 s (CF3). HRMS (MALDI): C17H14F3 found 275.1042 [M + H]+, calcd 275.1038.
CH), 7.00 d (2Harom., J 7.8 Hz), 7.12 s (1Harom.), 7.13 d (2Harom., J 7.8 Hz), 7.18 d (1Harom., J 7.9 Hz), 7.43 d (1Harom., J 7.9 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2 (Me), 21.6 (Me), 55.1 (C1), 120.5, 122.6 q (CF3, J 270.0 Hz), 125.3, 127.9, 128.2, 129.8, 134.3, 134.3 q (C3, J 34.2 Hz), 135.5, 137.0, 137.2, 140.2 q (C2, J 5.1 Hz). 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.05 s (CF3). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1210.
CH), 7.01 d (2Harom., J 8.6 Hz), 7.25–7.30 m (2Harom.), 7.37 m (1Harom.), 7.54 d (1Harom., J 7.5 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 54.9 (C1), 55.4 (OMe), 114.5, 120.9, 122.6 q (CF3, J 270.0 Hz), 124.5, 126.9, 127.4, 128.8, 129.0, 134.3 q (C3, J 34.2 Hz), 138.1, 141.4 q (C2, J 5.0 Hz), 148.3, 159.1. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.03 s (CF3). HRMS (MALDI): C17H14F3O found 291.0991 [M + H]+, calcd 291.0998.
CH), 7.02 d (2Harom., J 8.7 Hz), 7.25–7.31 m (2Harom.), 7.36 m (1Harom.), 7.55 d (1Harom., J 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 54.9 (C1), 55.4 (OMe), 114.5, 120.9, 122.6 q (CF3, J 270.0 Hz), 124.5, 126.9, 127.4, 128.8, 129.0, 134.3 q (C3, J 34.2 Hz), 138.1, 141.4 q (C2, J 5.0 Hz), 148.3, 159.1. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.02 s (CF3). HRMS (MALDI): C17H14F3O found 291.0991 [M + H]+, calcd 291.1002.
CH), 7.05 c (1Harom.), 7.08–7.10 m (2Harom.), 7.27–7.33 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.6 (C1), 56.3 (OMe), 56.4 (OMe), 104.0, 108.1, 122.6 q (CF3, J 269.9 Hz), 127.5, 128.0, 129.1, 130.8, 134.0 q (C3, J 34.1 Hz), 137.4, 139.8 q (C2, J 5.2 Hz), 140.9, 149.0. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −63.95 s (CF3). HRMS (MALDI): C18H16F3O2 found 321.1097 [M + H]+, calcd 321.1095.
CH + 1Harom.), 6.89 dd (1Harom., J 8.3 Hz, J 2.3 Hz), 7.01 d (2Harom., J 8.6 Hz), 7.42 d (Harom., J 8.4 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 54.8 (C1), 55.4 (OMe), 55.7 (OMe), 110.9, 113.0, 114.5, 121.4, 122.6 q (CF3, J 269.9 Hz), 129.0, 129.2, 131.0, 133.8 q (C3, J 34.1 Hz), 139.2 q (C2, J 5.1 Hz), 150.4, 159.1, 159.5. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.11 s (CF3). HRMS (MALDI): C18H16F3O2 found 321.1097 [M + H]+, calcd 321.1115.
CH), 7.2–7.5 m (6Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.4 (Me), 42.2 (C1), 56.1 (2OMe), 111.3, 120.4, 123.5 q (CF3, J 273.3Hz), 125.3, 127.6, 129.8, 130.2, 139.2, 139.4 q (C3, J 34 Hz), 140.1 q (C2, J 5.0Hz), 148.6. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.04 s (CF3). HRMS (MALDI): C19H18F3O2 found 335.1253 [M + H]+, calcd 335.1267.
:
3j2 1.25
:
1). Compound 3j1: 1H NMR (CDCl3, 400 MHz) (from the spectrum of a mixture of isomers) δ, ppm: 2.26 s (3H, Me), 2.34 s (3H, Me), 4.67 m (1H, C1H), 6.93 m (1H,
CH), 7.08 c (1Harom.), 7.10–7.12 m (2Harom., J 1.5 Hz), 7.22 d (1Harom., J 7.7 Hz), 7.24–7.31 m (3Harom.). 13C NMR (CDCl3, 100 MHz) (from the spectrum of a mixture of isomers, some signals) δ, ppm: 20.1 (Me), 20.2 (Me), 55.2 (C1), 122.64 q (CF3, J 270.0 Hz), 134.5 q (C3, J 34.1 Hz), 140.1 q (C2, J 5.1 Hz). 19F {1H} NMR (CDCl3, 376 MHz) (from the spectrum of a mixture of isomers) δ, ppm: −64.00 s (CF3) Mass spectrum (GC-MS), m/z (IotH., %): 288 [M]+ (100). Compound 3j2: 1H NMR (CDCl3, 400 MHz) (from the spectrum of a mixture of isomers) δ, ppm: 1.99 c (3H, Me), 2.30 c (3H, Me), 4.72 m (1H, C1H), 6.86 m (1H,
CH), 7.03–7.05 m (2Harom.), 7.24–7.31 m (4Harom.), 7.34 c (1Harom.). 13C NMR (CDCl3, 100 MHz) (from the spectrum of a mixture of isomers) δ, ppm: 15.8 (Me), 19.8 (Me), 55.4 (C1), 122.62 q (CF3, J 270.0 Hz), 133.4 q (C3, J 34.1 Hz), 140.9 q (C2, J 5.1 Hz). 19F {1H} NMR (CDCl3, 376 MHz) (from the spectrum of a mixture of isomers) δ, ppm: −64.10 s (CF3). For a mixture of isomers: 7.24–7.31 m (3Harom.A + 4Harom.B). Mass spectrum (GC-MS), m/z (IotH., %): 288 [M]+ (80). 13C NMR (CDCl3, 100 MHz) δ, ppm: 118.1, 121.9, 125.7, 127.3, 127.5, 128.0, 129.1, 129.5, 133.4, 135.6, 135.8, 135.9, 136.1, 136.7, 136.8, 137.7, 145.9, 146.1. HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1204 (for a mixture of isomers).
CH), 7.15 d (2Harom., J 6.6 Hz), 7.30–7.37 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 20.0 q (Me, J 4.7 Hz), 21.2 (Me), 54.6 (C1), 122.9 q (CF3, J 269.4 Hz), 123.1, 127.5, 128.1, 129.1, 131.3, 131.4, 133.8, 134.5 q (C3, J 33.9 Hz), 137.0, 137.8, 141.8 q (C2, J 6.3 Hz), 149.8. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −60.61 s (CF3). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1214.
CH + 2Harom.), 7.12 d (1Harom., J 7.7 Hz), 7.23–7.30 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 18.7 (Me), 19.8 q (Me, J 4.8 Hz), 54.5 (C1), 122.9 q (CF3, J 269.4 Hz), 127.3, 128.1, 128.6, 129.0, 129.2, 131.1, 131.9, 133.5 q (C3, J 33.9 Hz), 136.3, 137.0, 143.7 q (C2, J 6.4 Hz), 146.9. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −60.50 s (CF3). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1208.
CH + 2Harom.), 7.21–7.29 m (3Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 15.5 (Me), 19.5 (Me), 19.7 q (Me, J 4.8 Hz), 54.6 (C1), 122.9 q (CF3, J 269.4 Hz), 126.9, 127.2, 128.0, 128.6, 129.0, 132.7, 133.2 q (C3, J 33.8 Hz), 134.9, 135.7, 137.1, 142.8 q (C2, J 6.4 Hz), 147.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −60.69 d (CF3, J 1.8 Hz). HRMS (MALDI): C19H18F3 found 303.1355 [M + H]+, calcd 303.1361.
CH), 7.27–7.31 m (2Harom.), 7.36 dt (1Harom., J 7.2 Hz, J 1.8 Hz), 7.53 dd (1Harom., J 7.5 Hz, J 0.8 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 55.2 (C1), 101.3, 108.0, 108.7, 121.0, 121.4, 122.5 q (CF3, J 270.0 Hz), 124.5, 127.0, 127.5, 134.5 q (C3, J 34.2 Hz), 138.1, 141.1 q (C2, J 5.0 Hz), 147.1, 148.1, 148.2. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.07 s (CF3). HRMS (MALDI): C17H12F3O2 found 305.0784 [M + H]+, calcd 305.0792.
CH), 7.05 d (2Harom., J 7.7 Hz), 7.28–7.30 m (4Harom.), 7.37–7.43 m (1Harom.), 7.59 d (1Harom., J 6.9 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 54.9 (C1), 121.1, 122.4 q (CF3, J 270.0 Hz), 124.5, 127.2, 127.7, 129.3, 129.4, 133.5, 135.0 q (C3, J 34.4 Hz), 135.6, 138.1, 140.5 q (C2, J 4.9 Hz), 147.6. 19F {1H} NMR (CDCl3, 376 MHz) δ, ppm: −64.04 s (CF3). HRMS (MALDI): C16H11F335Cl found 295.0496 [M + H]+, calcd 295.0503.
CH, J 2.0 Hz), 7.32 t (1Harom., J 7.5 Hz), 7.40–7.50 m (4Harom.), 7.55–7.62 m (3Harom.), 7.65 d (1Harom., J 7.5 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.7 q (C1, J 29.4 Hz), 121.3, 124.8 q (C2, J 2.7 Hz), 124.9, 126.3 q (CF3, J 278.5 Hz), 126.4, 127.8, 128.5, 128.8, 129.5, 134.6, 138.8, 144.2, 149.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.35 dd (CF3, J 9.3 Hz, J 0.7 Hz). HRMS (MALDI): C16H12F3 found 261.0886 [M + H]+, calcd 261.0885.
CH, J 2.0 Hz), 7.30 d (2Harom., J 7.9 Hz), 7.34 t (1Harom., J 7.5 Hz), 7.43 t (1Harom., J 7.5 Hz), 7.52 d (2Harom., J 7.9 Hz), 7.58 d (1Harom., J 7.5 Hz), 7.68 d (1Harom., J 7.5 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.6 (Me), 52.7 q (C1, J 29.5 Hz), 121.3, 124.2 q (C2, J 2.7 Hz), 124.9, 126.3 q (CF3, J 278.5 Hz), 126.4, 127.7, 128.5, 129.5, 131.8, 138.5, 138.9 q (J 1.6 Hz), 144.4, 149.3. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.31 d (CF3, J 9.3 Hz). HRMS (MALDI): C17H14F3 found 275.1042 [M + H]+, calcd 275.1047.
CH, J 2.1 Hz), 7.16 d (1Harom., J 7.6 Hz), 7.30 d (2Harom., J 7.9 Hz), 7.38 s (2Harom.), 7.51 d (2Harom., J 7.9 Hz), 7.55 d (1Harom., J 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.4 (Me), 21.8 (Me), 52.4 (C1, J 29.4 Hz), 122.1, 124.5 q (C2, J 2.8 Hz), 124.6, 126.4 q (CF3, J 278.4 Hz), 127.1, 127.8, 129.5, 131.9, 136.0 q (J 1.8 Hz), 138.4, 138.5, 144.6, 149.3. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.49 d (CF3, J 9.4 Hz). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1209.
CH, J 2.1 Hz), 7.01 d (2Harom., J 8.8 Hz), 7.33 dt (1Harom., J 7.4 Hz, J 0.9 Hz), 7.42 t (1Harom., J 7.4 Hz), 7.54–7.58 m (3Harom.), 7.66 d (1Harom., J 7.4 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.7 q (C1, J 29.4 Hz), 55.5 (OMe), 114.3, 121.3, 123.7 q (C2, J 2.8 Hz), 124.9, 126.3 q (CF3, J 278.5 Hz), 127.2, 128.5, 129.1, 138.9, 144.5, 148.9, 160.0. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.34 d (CF3, J 9.5 Hz). HRMS (MALDI): C17H14F3O found 291.0991 [M + H]+, calcd 291.0990.
CH, J 1.9), 7.07 c (1Harom.), 7.22 c (1Harom.), 7.43 t (1Harom., J 7.3 Hz), 7.49 t (2Harom., J 7.3 Hz), 7.59 d (2Harom., J 7.3 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.5 q (C1, J 29.4 Hz), 56.3 (OMe), 56.5 (OMe), 104.9, 108.8, 123.5 q (C2, J 2.8 Hz), 126.3 q (CF3, J 278.5 Hz), 127.7, 128.6, 128.9, 131.3, 135.0, 137.3, 148.4, 149.2, 149.8. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.58 d (CF3, J 9.3 Hz). HRMS (MALDI): C18H16F3O2 found 321.1097 [M + H]+, calcd 321.1097.
CH, J 1.9 Hz), 6.98 d (1Harom., J 8.2 Hz), 7.09 d (1Harom., J 1.9 Hz), 7.14–7.19 m (2Harom.), 7.38 c (1Harom.), 7.54 d (1Harom., J 7.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.8 (Me), 52.3 q (C1, J 29.5 Hz), 56.1 (OMe), 56.2 (OMe), 111.2, 111.4, 120.4, 122.0, 124.2 q (C2, J 2.7 Hz), 124.6, 126.3 q (CF3, J 278.4 Hz), 127.2, 127.6, 136.0 d (J 1.9 Hz), 138.5, 144.6, 149.1, 149.3 149.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.48 d (CF3, J 9.3 Hz). HRMS (MALDI): C19H18F3O2 found 335.1253 [M + H]+, calcd 335.1258.
CH, J 2.0 Hz), 7.27–7.31 m (1Harom.), 7.40–7.50 m (4Harom.), 7.60 d (2Harom., J 8.4 Hz). 13C NMR (CDCl3, 100 MHz) (from the spectrum of a mixture of isomers, some signals) δ, ppm: 20.1 (Me), 20.3 (Me), 55.4 q (C1, J 29.4 Hz), 124.0 q (C2, J 2.6 Hz), 126.4 q (CF3, J 278.5 Hz). 19F NMR (CDCl3, 376 MHz) (from the spectrum of a mixture of isomers) δ, ppm: −67.45 d (CF3, J 9.0 Hz). Mass spectrum (GC-MS), m/z (IotH., %): 288 [M]+ (100). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1202 (for a mixture of isomers).
CH, J 2.1 Hz), 6.98 c (1Harom.), 7.18 c (1Harom.), 7.41–7.50 m (3Harom.), 7.57–7.59 m (2Harom.). 13C NMR (CDCl3, 100 MHz) δ, ppm: 20.0 q (Me, J 3.7 Hz), 21.5 (Me), 52.0 q (C1, J 29.2 Hz), 119.9, 125.9 q (C2, J 3.1 Hz), 126.7 q (CF3, J 279.9 Hz), 128.0, 128.5, 128.8, 129.7, 134.2, 135.0, 135.2, 138.7, 145.3, 149.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −63.90 dd (CF3, J 8.2 Hz, J 1.3 Hz). HRMS (MALDI): C18H16F3 found 289.1199 [M + H]+, calcd 289.1207.
CH, J 2.1 Hz), 7.35 dt (1Harom., J 7.4 Hz, J 0.9 Hz), 7.41–7.46 m (3Harom.), 7.50–7.55 m (3Harom.), 7.67 d (1Harom., J 7.4 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.8 q (C1, J 29.6 Hz), 121.1, 125.1, 125.2 q (C2, J 2.8 Hz), 126.1 q (CF3, J 278.6 Hz), 126.7, 128.7, 129.1, 129.2, 133.1, 134.6, 138.7, 143.9, 148.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −67.23 d (CF3, J 9.3 Hz). HRMS (MALDI): C16H11F3Cl found 295.0496 [M + H]+, calcd 295.0496.
CH), 7.03 dt (1Harom., J 8.5 Hz, J 2.2 Hz), 7.25–7.35 m (3Harom.), 7.37 c (1Harom.), 7.60 dd (1Harom., J 7.7 Hz, J 5.4 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.7 (Me), 20.0 (Me), 52.2 q (C1, J 29.7 Hz), 109.0 d (J 24.2 Hz), 113.0 d (J 23.2 Hz), 125.1, 125.8 d (J 9.3 Hz), 126.0 q (C2, J 2.6 Hz), 126.1 q (CF3, J 278.5 Hz), 128.9, 130.2, 131.6, 134.2 m, 137.4 d (J 25.7 Hz), 146.8 d (J 9.0 Hz), 148.8 d (J 2.9 Hz), 163.6 d (J 245.3 Hz). 19F NMR (CDCl3, 376 MHz) δ, ppm: −113.55 to −113.48 m (1Farom.), −67.52 d (CF3, J 9.1 Hz). HRMS (MALDI): C18H15F4 found 307.1104 [M + H]+, calcd 307.1107.
CH, J 2.1 Hz), 6.97 d (1Harom., J 8.2 Hz), 7.02 dt (1Harom., J 8.7 Hz, J 2.4 Hz), 7.06 d (1Harom., J 1.9 Hz), 7.14 dd (1Harom., J 8.2 Hz, J 1.9 Hz), 7.26 dd (1Harom., J 9.0 Hz, J 2.4 Hz), 7.58 dd (Harom., J 8.0 Hz, J 5.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.2 q (C1, J 29.8 Hz), 56.1 (OMe), 56.2 (OMe), 108.9 d (J 24.3 Hz), 110.9, 111.5, 113.1 d (J 23.2 Hz), 120.3, 125.8 q (C2, J 2.6 Hz), 125.9 d (J 9.2 Hz), 126.0 q (CF3, J 278.5 Hz), 126.8, 134.1 m, 146.7 d (J 8.8 Hz), 148.5 d (J 2.9 Hz), 149.6 d (J 44.1 Hz), 163.6 d (J 245.5 Hz). 19F NMR (CDCl3, 376 MHz) δ, ppm: −113.31 dt (1Farom., J 9.0 Hz, J 5.1 Hz), −67.51 d (CF3, J 8.9 Hz). HRMS (MALDI): C18H15F4O2 found 339.1003 [M + H]+, calcd 339.1009.
Footnote |
| † Electronic supplementary information (ESI) available: 1H, 13C, 19F NMR spectra of compounds, and data on DFT calculations. See DOI: 10.1039/c7ob00406k |
| This journal is © The Royal Society of Chemistry 2017 |